Woodside Energy Group signs LNG supply agreements with Uniper SE and Stonepeak, advancing their Louisiana LNG project towards final investment decision.
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
(BPT) - Actor, author and comedian Kenan Thompson can find humor in just about anything. However, one thing he cannot find the humor in is the heartburn due to Non-Erosive gastroesophageal reflux disease (Non-Erosive GERD) - and he is sharing that GERD is no joke. "Even though GERD is a funny word, it's definitely not a funny thing to have," said Thompson. When Thompson first started experiencing heartburn about two years ago, it started to affect him more and more frequently, but he didn't know exactly what was causing it or how to treat it. He tried taking other medications, but they just weren't doing the trick.
European Central Bank President Christine Lagarde showed an increased sense of urgency in light of ongoing trade tensions and increased disinflationary pressures.
The long end of the Treasury bond market is in danger of breaking down to the point that yields are on the verge of erupting higher. This is what debt spirals are made of.
Wall Street saw a rebound in risk appetite on Thursday ahead of the long Easter weekend, as President Donald Trump signaled positive momentum in trade negotiations.
Fremont, CA – April 17, 2025 – Lam Research Corporation (NASDAQ: LRCX), a leading provider of wafer fabrication equipment for the semiconductor industry, experienced a slight decline in its stock price today, closing at $64.24, down 0.90 (1.40%) as of 1:37 PM EDT. The stock opened at $65.
The device, known as the Layer 7 Cortical Interface, is a thin, flexible microelectrode array designed to record and stimulate neural activity without penetrating brain tissue.
NVIDIA shares are trading lower by 3.3% during Thursday's session. Fresh U.S. export restrictions on AI chips to China rattled investor confidence and triggered significant financial hits.
The new designation is in addition to the existing Regenerative Medicine Advanced Therapy, Orphan Drug, and Fast Track designations granted to AMT-130.
The Swiss franc is trading very close to all-time lows. There's growing speculation about whether the Swiss National Bank (SNB) is preparing to intervene.
